Blood, clotting, Red Sox, repeat. Chief of Hematology Service at Memorial Sloan Kettering Cancer Center #MSKCC
Joined March 2011
- Tweets 256
- Following 757
- Followers 543
- Likes 993
23 Photos and videos
Jeff Zwicker, MD retweeted
Apr 17
Excited for the opening of the 13th edition of @ICTHIC @icthicmagazine with exciting new data, talks by @MarcCarrier1 @AngLi_MD @aureliendelluc @LeaderAvi @isabellemahe1 @KSanfilippoMD many others Karpatkin Memorial Lecture by @jzbos all on day 1 alone!
3
15
716
Jeff Zwicker, MD retweeted
6 Dec 2025
#ASH25: Divyash Shah will present the results of a study assessing the comparative incidence of venous thromboembolism in patients with chemotherapy-induced thrombocytopenia treated with romiplostim. @MSKCancerCenter @ASH_hematology
Learn more: bit.ly/3Ks5LH9
3
7
1,056
Jeff Zwicker, MD retweeted
5 Dec 2025
Tomorrow morning at #ASH25, Varun Iyengar, MD, will present a study evaluating venous thromboembolism risk factors found via genomic profiling cross subtypes of B-cell #lymphoma. @MSKCancerCenter @ASH_hematology #lymsm
Learn more: bit.ly/4pucLmc
5
17
1,812
Jeff Zwicker, MD retweeted
27 Oct 2025
🙏 @jzbos & @MSKCancerCenter for the opportunity to present @StopTheClot #VTEadvocacy work today at the benign hematology event-now in its 10th year! Double 🙏 for always including #VTE patients in this world class event! #stoptheclot #MSK #CAT #MASAB
2
4
264
Jeff Zwicker, MD retweeted
19 Jul 2025
Fascinating paper from Chrysaf @jzbos @LeaderAvi @rushadpatell et al suggesting nearly half the rate of VTE in individuals with FXI deficiency and cancer - important clinical mplications as FXI targeting agents are being developed for cancer VTE
sciencedirect.com/science/ar…
5
12
478
Jeff Zwicker, MD retweeted
29 Mar 2025
Practice-changing paper in @nejm by @isabellemahe1 @MarcCarrier1 API-CAT team proves that apixaban dose can be reduced after 6mo of anticoag rx with no loss of efficacy and less bleeding. Congrats to the team! nejm.org/doi/full/10.1056/NE…
2
56
130
10,968
10 Oct 2024
We have a great program. Not too late to signup!
4
248
2 Aug 2024
Making plans for ASH attendance? Don’t forget to arrive in time for the Friday Scientific Workshop on Malignancy and Coagulation! Friday Dec 6, 2-5pm. @ASH_hematology @Lbkreuziger
hematology.org/meetings/annu…
3
93
Jeff Zwicker, MD retweeted
23 Jun 2024
Can low level of CD200R1 help to predict cancer/associated thrombosis? ⬇️ CD200R1 is associated with ⬆️ IL17a leading to thrombin generation and vascular inflammation at #ISTH2024
Nice application of machine learning and plasma proteomics!
@isth @jzbos @rushadpatell
7
22
2,640
Jeff Zwicker, MD retweeted
16 Feb 2024
Don't miss out on our NEW CME/CNE Webinar Series!
Join experts @aakonc, @TzufeiWang and @jzbos as they guide you through #BestPractices in diagnosing, managing, and preventing VTE in cancer.
Learn more: ow.ly/JP8550QCl0m
#oncology #CancerPreventionMonth #Healthcare
ALT Updates in the Prevention, Diagnosis, and Management of Venous Thromboembolism in Cancer: Fundamentals of Optimizing Patient Care in Clinical Practice
5
7
675
Jeff Zwicker, MD retweeted
14 Dec 2023
Balancing safety &efficacy of anticoagulation in primary vs. metastatic brain #cancer is nuanced.
Meta-analysis systematic review suggest DOACs > LMWH in primary, but not metastatic, brain tumors.
@varun_pdx
@ShubhAgrawalMD
@rushadpatell
@jzbos
jthjournal.org/article/S1538…
11
27
4,406
Jeff Zwicker, MD retweeted
11 Dec 2023
Please check out @cywilkinsmd talking about survival outcomes with Romiplostin use in chemotherapy induced thrombocytopenia #ASH23 @MSKCancerCenter @MSK_DeptOfMed @jzbos
Join hematologist-oncologist Dr. Cy R. Wilkins (@cywilkinsmd) for an oral session at #ASH23 TODAY at 3:15pm PST. Learn more here: bit.ly/3TmXk1I
1
3
11
2,148
Jeff Zwicker, MD retweeted
11 Dec 2023
Simon Mantha of the @MSKCancerCenter presented a dynamic risk model for cancer-associated venous thromboembolism that evaluated EHR data from 35K pts. This method could optimize outpatient intervention during periods of high thrombotic risk. #ASH23 @jzbos buff.ly/482OryI
1
3
429
Jeff Zwicker, MD retweeted
9 Dec 2023
Dear @ASH_hematology this is not acceptable. Why could you not anticipate this, it is the only educational session on thrombosis at #ASH23 #ASH2023. Do we get our registration fee back, if we do not get a seat?
9 Dec 2023
#ASH23 what is happening? The only thrombosis session of the afternoon and people are in line and can’t enter the room!!
2
3
26
9,782
Jeff Zwicker, MD retweeted
9 Dec 2023
VKA instead of LMWH or DOAC for the management of cancer-associated thrombosis? Counterintuitive but 3⃣ studies have now reported ⬆️ survival with VKA.
Could it be due to anti-cancer effect (e.g., gas6 inhibition)? #ASH23
pubmed.ncbi.nlm.nih.gov/3449…
pubmed.ncbi.nlm.nih.gov/3561…
8
34
97
15,045
20 Nov 2023
Don’t forget ASH Friday Workshop on Coagulation and Malignancy will be held Dec 8 from 2-5pm! A great panel of speakers. hematology.org/meetings/annu…
@Lbkreuziger @ASH_hematology
20 Sep 2022
📣Reminder📣
ASH Friday Workshop on Coagulation and Malignancy on Dec 9 (2-5pm).
The only Friday ASH workshop for the HT community!
🚨We are accepting submissions for a few late breaking speaker abstracts.🚨
hematology.org/meetings/annu…
@Lbkreuziger @ASH_hematology
4
17
3,462
The ISTH SSC Subcommittee on Hemostasis and Malignancy has published new guidance in @JTHjournal on the management of chemotherapy induced thrombocytopenia. isth.org/news/655218/ISTH-SS…
10
15
2,830